- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
19 result(s) found for: Solar erythema.
Displaying page 1 of 1.
EudraCT Number: 2013-000629-30 | Sponsor Protocol Number: 06022013 | Start Date*: 2013-04-09 | |||||||||||
Sponsor Name:Department of surgery, Herlev Hospital | |||||||||||||
Full Title: The sun protective effect of melatonin: a randomized, placebo-controlled, double-blinded study on healthy volunteers. | |||||||||||||
Medical condition: Erythema after sun exposure in healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004616-31 | Sponsor Protocol Number: FR1 | Start Date*: 2008-04-11 | |||||||||||
Sponsor Name:Universitair Medisch Cemtrum Utrecht | |||||||||||||
Full Title: Prevention of neutrophil induced extracellular matrix damage following skin exposure to solar simulating radiation (SSR) | |||||||||||||
Medical condition: sunburn (erythema solaris), photoaging (elastosis solaris) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001701-33 | Sponsor Protocol Number: 58161 | Start Date*: 2017-05-19 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Photodynamic therapy without curettage | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002756-11 | Sponsor Protocol Number: 43739 | Start Date*: 2014-08-27 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Photodynamic therapy with varying application times for treatment of actinic keratosis | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003003-29 | Sponsor Protocol Number: 49301 | Start Date*: 2015-08-31 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: 5-flourouracil treatment prior to photodynamic therapy of actinic keratosis on the hands | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003020-31 | Sponsor Protocol Number: 24-08-2015version3.0 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg University Hospital | |||||||||||||
Full Title: Pulse-Daylight-Photodynamic Therapy of Actinic Keratoses | |||||||||||||
Medical condition: Actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002143-16 | Sponsor Protocol Number: CUV023 | Start Date*: 2010-02-04 | |||||||||||
Sponsor Name:Clinuvel Pharmaceuticals Limited | |||||||||||||
Full Title: A Phase III, multicentre, double–blind, placebo controlled, cross over study to evaluate the safety and efficacy of subcutaneous bioresorbable implants of afamelanotide in the treatment of solar ur... | |||||||||||||
Medical condition: Solar urticaria (SU) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005034-20 | Sponsor Protocol Number: 228-13/06 | Start Date*: 2007-03-08 | |||||||||||
Sponsor Name:Klinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf | |||||||||||||
Full Title: Doppelblinde, prospektiv-randomisierte, intraindividuell-halbseitenvergleichende Studie zur klinischen Wirksamkeit von Verrumal® Lsg. bei aktinischen Keratosen gegen Vehikel: Investigator-initiiert... | |||||||||||||
Medical condition: Actinic keratosis is a precancerous skin growth usually caused by sun exposure. Symptoms: Rough and dry textured skin lesion, macule, patch, or growth on the skin Located on sun-exposed areas. Acti... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004524-36 | Sponsor Protocol Number: FESB-DE-310 | Start Date*: 2006-10-24 | |||||||||||
Sponsor Name:Novartis Consumer Health SA | |||||||||||||
Full Title: A randomized, double-blind, vehicle controlled, single center, intra-individual comparative study of the efficacy and safety of diclofenac sodium 1 mg/g (0.1%) gel in subjects with painful UV-induc... | |||||||||||||
Medical condition: Relief of pain and erythema associated with superficial sunburn | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005438-39 | Sponsor Protocol Number: 40736 | Start Date*: 2014-04-01 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Pulse photodynamic therapy with methyl aminolevulinate activated by a halogen lamp | |||||||||||||
Medical condition: Actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002408-97 | Sponsor Protocol Number: MALvsALA | Start Date*: 2015-12-16 | |||||||||||
Sponsor Name:Dr. Carlos Serra | |||||||||||||
Full Title: Comparative Study, intraindividual to evaluate efficacy and safety of the treatment of actinic keratosis with photodinamic therapy between methyl aminolevulinate cream and aminolevulinic acid nanos... | |||||||||||||
Medical condition: Actinic Keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002583-80 | Sponsor Protocol Number: 38814 | Start Date*: 2013-09-06 | |||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg University Hospital | |||||||||||||
Full Title: Treatment of Actinic Keratoses with Ingenol Mebutate and topical glucocorticosteroid - a safety study | |||||||||||||
Medical condition: Actinic Keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002331-18 | Sponsor Protocol Number: 48739 | Start Date*: 2016-05-25 | |||||||||||
Sponsor Name:Bispebjerg Hospital, Department of Dermatology | |||||||||||||
Full Title: Pretreatment with ablative fractional laser and microdermabrasion before photodynamic therapy for actinic keratoses in field-cancerized skin | |||||||||||||
Medical condition: Patients over 18 years of age two similar areas with actinic keratoses and field-cancerized skin of each at least 50 cm2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000991-26 | Sponsor Protocol Number: SUN-PDT1 | Start Date*: 2008-04-15 | |||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg Hospital | |||||||||||||
Full Title: A RANDOMIZED, MULTICENTER STUDY OF DAYLIGHT MEDIATED PHOTODYNAMIC THERAPY WITH METVIX® CREAM 160 mg/g IN PATIENTS WITH MULTIPLE ACTINIC KERATOSIS ON THE FACE AND SCALP | |||||||||||||
Medical condition: Actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004538-32 | Sponsor Protocol Number: LIMTOP-I | Start Date*: 2012-04-04 | |||||||||||
Sponsor Name:Moberg Derma | |||||||||||||
Full Title: A double-blind, randomized, multi-centre, vehicle-controlled study of efficacy and safety of a new topical formulation with imiquimod (Limtop) applied 1,3 or 7 times weekly during 2 x 2 weeks treat... | |||||||||||||
Medical condition: 5-20 clinically confirmed, palpable or visible (grade I or II according to modified Olsen score), nonhyperkeratotic, nonhypertrophic, AK lesions located within a contiguous (25 - 100 cm²) area on t... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000490-20 | Sponsor Protocol Number: Galderma-Metvix | Start Date*: 2018-02-08 | |||||||||||||||||||||
Sponsor Name:A.O.U. Università degli Studi della Campania "Luigi Vanvitelli" | |||||||||||||||||||||||
Full Title: Evaluation of efficacy, safety and patient¿s satisfaction of daylight photodynamic therapy (DL-PDT) in the treatment of actinic keratosis on the face and scalp and related field cancerization carri... | |||||||||||||||||||||||
Medical condition: actinic keratosis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003436-74 | Sponsor Protocol Number: 01-18/629-15 | Start Date*: 2019-07-10 | |||||||||||
Sponsor Name:Intas Pharmaceuticals Ltd | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-controlled, Three-arm, Parallel Assignment, Multi-Centre, Therapeutic Equivalence Study of Two Fluorouracil 5% Topical Cream Formulations in Adult Pat... | |||||||||||||
Medical condition: Actinic Keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) RO (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000893-32 | Sponsor Protocol Number: 008171BLT | Start Date*: 2014-02-17 | |||||||||||
Sponsor Name:Queen Mary University of London | |||||||||||||
Full Title: Squamous cell carcinoma prevention in organ transplant recipients using topical treatments: a feasibility study (SPOT) | |||||||||||||
Medical condition: Actinic keratosis (and cutaneous squamous cell carcinoma) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004110-10 | Sponsor Protocol Number: 2ABC | Start Date*: 2017-12-21 | ||||||||||||||||
Sponsor Name:Medical University of Warsaw | ||||||||||||||||||
Full Title: Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The t... | ||||||||||||||||||
Medical condition: Scar or cutis laxa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
